AU2002224595A1 - Antitumor agents - Google Patents

Antitumor agents

Info

Publication number
AU2002224595A1
AU2002224595A1 AU2002224595A AU2459502A AU2002224595A1 AU 2002224595 A1 AU2002224595 A1 AU 2002224595A1 AU 2002224595 A AU2002224595 A AU 2002224595A AU 2459502 A AU2459502 A AU 2459502A AU 2002224595 A1 AU2002224595 A1 AU 2002224595A1
Authority
AU
Australia
Prior art keywords
antitumor agents
antitumor
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002224595A
Other languages
English (en)
Inventor
Tosiyuki Inui
Noriyasu Kuno
Gou Shinohara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nisshin Oil Mills Ltd
Original Assignee
Nisshin Oil Mills Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nisshin Oil Mills Ltd filed Critical Nisshin Oil Mills Ltd
Publication of AU2002224595A1 publication Critical patent/AU2002224595A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/191Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
AU2002224595A 2000-07-31 2001-07-25 Antitumor agents Abandoned AU2002224595A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2000-230254 2000-07-31
JP2000230254 2000-07-31
JP2000366297 2000-11-30
JP2000-366297 2000-11-30
PCT/JP2001/006393 WO2002009719A1 (fr) 2000-07-31 2001-07-25 Agents antitumoraux

Publications (1)

Publication Number Publication Date
AU2002224595A1 true AU2002224595A1 (en) 2002-02-13

Family

ID=26596992

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002224595A Abandoned AU2002224595A1 (en) 2000-07-31 2001-07-25 Antitumor agents

Country Status (6)

Country Link
US (1) US20030153538A1 (fr)
EP (1) EP1321145A4 (fr)
CN (1) CN1450900A (fr)
AU (1) AU2002224595A1 (fr)
CA (1) CA2418117A1 (fr)
WO (1) WO2002009719A1 (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869535A (en) 1995-03-21 1999-02-09 The Board Of Trustees Of The University Of Illinois Method and composition for selectively inhibiting melanoma
EP1309605A1 (fr) * 2000-08-18 2003-05-14 The Board Of Trustees Of The University Of Illinois Promedicaments de derives de l'acide betulinique pour le traitement du cancer et du vih
FR2822821B1 (fr) * 2001-04-03 2004-05-07 Pharmascience Lab Extrait de coques de graines de lupin contenant du lupeol, en particulier extrait riche en lupeol et son procede de preparation
AU2002367429A1 (en) * 2001-12-28 2003-07-24 The Nisshin Oillio, Ltd. Apoptosis inductor
JP2005527613A (ja) * 2002-05-24 2005-09-15 グレイストーン メディカル グループ、インコーポレイテッド 抗癌製剤
CN1243538C (zh) * 2002-11-21 2006-03-01 武汉利元亨药物技术有限公司 熊果酸豆磷脂纳米粒冻干粉针及制备方法
KR100559489B1 (ko) * 2003-08-05 2006-03-10 한국생명공학연구원 대추 추출물 및 그로부터 분리된 화합물을 유효성분으로함유하는 항암제 및 암전이 억제제
EP1802648A2 (fr) * 2004-09-10 2007-07-04 Cornell Research Foundation, Inc. Derives de betulinol utilises en tant qu'agents anticancereux
CA2970873C (fr) * 2005-05-09 2022-05-17 E. R. Squibb & Sons, L.L.C. Anticorps monoclonaux humains pour mort programmee 1 (mp-1) et procedes pour traiter le cancer en utilisant des anticorps anti-mp-1 seuls ou associes a d'autres immunotherapies
WO2007112043A2 (fr) * 2006-03-23 2007-10-04 Advanced Life Sciences Inc. Triterpenoides pentacycliques synthetiques et derives d'acide betulinique et de betuline
ES2301369B1 (es) * 2006-06-21 2009-06-12 Consejo Superior Investig. Cientificas Utilizacion del editrodiol para la preparacion de un medicamento inductor de muerte por desarraigo en celulas malignas de tumores solidos.
ES2328999B1 (es) 2008-04-03 2010-10-27 Biomaslinic S.L. Uso del acido maslinico para el tratamiento de patologias y sus sintomas mediante la inhibicion de cox-2.
CN102008715B (zh) * 2009-09-07 2013-02-20 华东师范大学 抗肿瘤的MA-TNFα药物组合物及其应用
JP5548874B2 (ja) * 2010-03-31 2014-07-16 富山県 がん免疫抑制解除剤及びがん免疫治療用組成物
CN102241723B (zh) * 2010-05-11 2015-06-03 上海开拓者医药发展有限公司 一种熊果酸盐及其制备方法和晶体
JP5808797B2 (ja) * 2010-05-20 2015-11-10 ユニバーシティ オブ アイオワ リサーチ ファウンデーション 筋萎縮を阻害するための方法
US11090313B2 (en) 2010-05-20 2021-08-17 University Of Iowa Research Foundation Methods for inhibiting muscle atrophy
CN102091078A (zh) * 2010-09-27 2011-06-15 林秀坤 山楂酸的抗肝癌作用及其药物制剂
CN102225068A (zh) * 2010-09-27 2011-10-26 林秀坤 山楂酸的抗卵巢癌作用及其药物制剂
CN102106858A (zh) * 2010-09-27 2011-06-29 林秀坤 山楂酸的抗宫颈癌作用及其药物制剂
CN102106861A (zh) * 2010-09-27 2011-06-29 林秀坤 山楂酸的抗结肠癌作用及其药物制剂
CN102106859A (zh) * 2010-09-27 2011-06-29 林秀坤 山楂酸的抗乳腺癌作用及其药物制剂
CN102151276A (zh) * 2010-11-07 2011-08-17 林秀坤 山楂酸的抗胰腺癌作用及其药物制剂
AU2012268036B2 (en) 2011-06-06 2017-04-06 THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF STATE OF THE DEPARTMENT OF VETERANS AFFAIRS Methods of inhibiting muscle atrophy
JP2013010715A (ja) * 2011-06-29 2013-01-17 Nippon Flour Mills Co Ltd う蝕予防剤、歯周病予防剤及び口腔用組成物
RU2475025C1 (ru) * 2011-07-27 2013-02-20 Федеральное государственное образовательное учреждение высшего профессионального образования "Кубанский государственный аграрный университет" Средство для обработки семян зерновых и зернобобовых культур, пораженных фузариозом
CN103202898B (zh) * 2013-03-29 2014-04-16 阚兆云 中药组合物及其制备方法
EP3681507B8 (fr) * 2017-09-13 2024-03-13 Emmyon, Inc. Sels de diéthanolamine et de morpholine d'acide ursolique
CN108686220A (zh) * 2018-07-13 2018-10-23 刘慧荣 一种针对甲状腺癌的抗肿瘤剂
CN112353827B (zh) * 2020-12-07 2022-05-27 山东省分析测试中心 Vsm在制备治疗横纹肌肉瘤药物中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US400186A (en) * 1889-03-26 Portable wash-stand
JPS6357519A (ja) * 1986-08-28 1988-03-12 Minofuaagen Seiyaku Honpo:Goushi 発癌プロモ−タ−抑制剤
JPH064563B2 (ja) * 1986-08-29 1994-01-19 理化学研究所 トリテルペン化合物及び制癌剤
JPH01143832A (ja) * 1987-12-01 1989-06-06 Toa Nenryo Kogyo Kk 制癌剤
US5962527A (en) * 1995-03-21 1999-10-05 The Board Of Trustees Of The University Of Illinois Method and composition for treating cancers
DE29508355U1 (de) * 1995-05-24 1996-09-26 Linck Masch Gatterlinck Vorrichtung zum Zerlegen von Baumstämmen in Holzerzeugnisse und Fräskopf für eine solche Vorrichtung
JP3984310B2 (ja) * 1995-06-22 2007-10-03 日本製粉株式会社 グリセロリン酸脱水素酵素阻害剤
JP3041232B2 (ja) * 1995-11-16 2000-05-15 日本ケミカルリサーチ株式会社 癌転移抑制剤
US5916919A (en) * 1997-06-27 1999-06-29 Dalhousie University Retrovirus protease inhibitors

Also Published As

Publication number Publication date
EP1321145A4 (fr) 2006-03-22
CA2418117A1 (fr) 2003-01-30
EP1321145A1 (fr) 2003-06-25
CN1450900A (zh) 2003-10-22
US20030153538A1 (en) 2003-08-14
WO2002009719A1 (fr) 2002-02-07

Similar Documents

Publication Publication Date Title
AU2002224595A1 (en) Antitumor agents
AU2002221344A1 (en) Antiviral agents
AU2001262847A1 (en) Language-understanding
AU2001228708A1 (en) Coin-validation arrangement
AU2001292739A1 (en) 1-oxorapamycins
AU2001254546A1 (en) Aminopiperidines
AU2000267458A1 (en) Hypercomputer
AU2001288040A1 (en) Homeostasis-maintaining agents
AU2002214284A1 (en) Anti-helicobacterial agents
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001220246A1 (en) Neckphone
AU2001258349A1 (en) Bisacylguanidine
AU2001279754A1 (en) Indoloquinazolinones
AU2001285886A1 (en) 2-guanidino-4-aryl-quinazoline
AU2001290931A1 (en) Ski-snowboard
AU2001293852A1 (en) Sulfonylguanidine
AU2001258924A1 (en) Microsatellite-aflp
AU7446000A (en) Antitumor agents
AU2001281921A1 (en) Bdellosomes
AU2001246864A1 (en) Hypotensors
AU2001291876A1 (en) Triazolo-epothilones
AU2001262711A1 (en) Cytoprotectors
AU2001226668A1 (en) Crankshaft-starter-generator
AU2001260192A1 (en) Glycinamides
AU2001284173A1 (en) Calycins